1	Heat	Heat	_	_	_	_	_	_	_
2	shock	shock	_	_	_	_	_	_	_
3	induces	induce	_	_	_	_	_	_	_
4	HIV-1	HIV-1	_	_	_	_	_	_	_
5	replication	replication	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	chronically	chronically	_	_	_	_	_	_	_
8	infected	infected	_	_	_	_	_	_	_
9	promyelocyte	promyelocyte	_	_	_	_	_	_	_
10	cell	cell	_	_	_	_	_	_	_
11	line	line	_	_	_	_	_	_	_
12	OM10.1	om10.1	_	_	_	_	_	_	_
13	.	.	_	_	_	_	_	_	_

1	A	a	_	_	_	_	_	_	_
2	long	long	_	_	_	_	_	_	_
3	period	period	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	clinical	clinical	_	_	_	_	_	_	_
6	latency	latency	_	_	_	_	_	_	_
7	before	before	_	_	_	_	_	_	_
8	development	development	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	symptoms	symptom	_	_	_	_	_	_	_
11	is	be	_	_	_	_	_	_	_
12	characteristic	characteristic	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	human	human	_	_	_	_	_	_	_
15	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
16	virus	virus	_	_	_	_	_	_	_
17	type	type	_	_	_	_	_	_	_
18	1	1	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	HIV-1	HIV-1	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	infection	infection	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	OM10.1	OM10.1	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	a	a	_	_	_	_	_	_	_
4	promyelocyte	promyelocyte	_	_	_	_	_	_	_
5	cell	cell	_	_	_	_	_	_	_
6	line	line	_	_	_	_	_	_	_
7	latently	latently	_	_	_	_	_	_	_
8	infected	infect	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	HIV-1	HIV-1	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	has	have	_	_	_	_	_	_	_
13	been	be	_	_	_	_	_	_	_
14	developed	develop	_	_	_	_	_	_	_
15	as	as	_	_	_	_	_	_	_
16	a	a	_	_	_	_	_	_	_
17	model	model	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	studying	study	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	mechanism	mechanism	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	viral	viral	_	_	_	_	_	_	_
24	latency	latency	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	activation	activation	_	_	_	_	_	_	_
28	of	of	_	_	_	_	_	_	_
29	virus	virus	_	_	_	_	_	_	_
30	expression	expression	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	found	find	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	this	this	_	_	_	_	_	_	_
5	latently	latently	_	_	_	_	_	_	_
6	infected	infected	_	_	_	_	_	_	_
7	cell	cell	_	_	_	_	_	_	_
8	line	line	_	_	_	_	_	_	_
9	with	with	_	_	_	_	_	_	_
10	heat	heat	_	_	_	_	_	_	_
11	shock	shock	_	_	_	_	_	_	_
12	at	at	_	_	_	_	_	_	_
13	42	42	_	_	_	_	_	_	_
14	degrees	degree	_	_	_	_	_	_	_
15	C	c	_	_	_	_	_	_	_
16	for	for	_	_	_	_	_	_	_
17	2	2	_	_	_	_	_	_	_
18	h	h	_	_	_	_	_	_	_
19	resulted	result	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	high	high	_	_	_	_	_	_	_
23	level	level	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	HIV-1	HIV-1	_	_	_	_	_	_	_
26	production	production	_	_	_	_	_	_	_
27	without	without	_	_	_	_	_	_	_
28	addition	addition	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	any	any	_	_	_	_	_	_	_
31	cytokines	cytokine	_	_	_	_	_	_	_
32	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	mechanism	mechanism	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	activation	activation	_	_	_	_	_	_	_
5	was	be	_	_	_	_	_	_	_
6	analyzed	analyze	_	_	_	_	_	_	_
7	by	by	_	_	_	_	_	_	_
8	using	use	_	_	_	_	_	_	_
9	anti-TNF-alpha	anti-tnf-alpha	_	_	_	_	_	_	_
10	antibody	antibody	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	various	various	_	_	_	_	_	_	_
13	inhibitors	inhibitor	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
4	level	level	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	culture	culture	_	_	_	_	_	_	_
7	supernatants	supernatant	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	below	below	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	sensitivity	sensitivity	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	an	an	_	_	_	_	_	_	_
14	ELISA	ELISA	_	_	_	_	_	_	_
15	assay	assay	_	_	_	_	_	_	_
16	system	system	_	_	_	_	_	_	_
17	,	,	_	_	_	_	_	_	_
18	addition	addition	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	anti-TNF-alpha	anti-tnf-alpha	_	_	_	_	_	_	_
21	antibody	antibody	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	culture	culture	_	_	_	_	_	_	_
24	medium	medium	_	_	_	_	_	_	_
25	could	could	_	_	_	_	_	_	_
26	partially	partially	_	_	_	_	_	_	_
27	suppress	suppress	_	_	_	_	_	_	_
28	the	the	_	_	_	_	_	_	_
29	heat	heat	_	_	_	_	_	_	_
30	shock	shock	_	_	_	_	_	_	_
31	induced	induce	_	_	_	_	_	_	_
32	HIV-1	HIV-1	_	_	_	_	_	_	_
33	production	production	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Staurosporine	Staurosporine	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	PKC	PKC	_	_	_	_	_	_	_
4	inhibitor	inhibitor	_	_	_	_	_	_	_
5	)	)	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	pentoxifylline	pentoxifylline	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	NF-kappa	NF-kappa	_	_	_	_	_	_	_
10	B	B	_	_	_	_	_	_	_
11	inhibitor	inhibitor	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	Ro5-3335	Ro5-3335	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	HIV-1	HIV-1	_	_	_	_	_	_	_
18	Tat	Tat	_	_	_	_	_	_	_
19	inhibitor	inhibitor	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	also	also	_	_	_	_	_	_	_
22	inhibited	inhibit	_	_	_	_	_	_	_
23	significantly	significantly	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	heat	heat	_	_	_	_	_	_	_
26	shock	shock	_	_	_	_	_	_	_
27	induced	induced	_	_	_	_	_	_	_
28	virus	virus	_	_	_	_	_	_	_
29	activation	activation	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	particular	particular	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	staurosporine	staurosporine	_	_	_	_	_	_	_
5	achieved	achieve	_	_	_	_	_	_	_
6	approximately	approximately	_	_	_	_	_	_	_
7	90	90	_	_	_	_	_	_	_
8	%	%	_	_	_	_	_	_	_
9	inhibition	inhibition	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	HIV-1	HIV-1	_	_	_	_	_	_	_
13	antigen	antigen	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	in	in	_	_	_	_	_	_	_
16	heat	heat	_	_	_	_	_	_	_
17	shock-treated	shock-treated	_	_	_	_	_	_	_
18	OM10.1	om10.1	_	_	_	_	_	_	_
19	at	at	_	_	_	_	_	_	_
20	a	a	_	_	_	_	_	_	_
21	non-toxic	non-toxic	_	_	_	_	_	_	_
22	concentration	concentration	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Although	although	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	mechanism	mechanism	_	_	_	_	_	_	_
4	of	of	_	_	_	_	_	_	_
5	HIV-1	HIV-1	_	_	_	_	_	_	_
6	activation	activation	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	heat	heat	_	_	_	_	_	_	_
9	shock	shock	_	_	_	_	_	_	_
10	has	have	_	_	_	_	_	_	_
11	not	not	_	_	_	_	_	_	_
12	been	be	_	_	_	_	_	_	_
13	fully	fully	_	_	_	_	_	_	_
14	elucidated	elucidate	_	_	_	_	_	_	_
15	yet	yet	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	it	it	_	_	_	_	_	_	_
18	is	be	_	_	_	_	_	_	_
19	presumed	presume	_	_	_	_	_	_	_
20	PKC	PKC	_	_	_	_	_	_	_
21	plays	play	_	_	_	_	_	_	_
22	an	an	_	_	_	_	_	_	_
23	important	important	_	_	_	_	_	_	_
24	role	role	_	_	_	_	_	_	_
25	in	in	_	_	_	_	_	_	_
26	HIV-1	HIV-1	_	_	_	_	_	_	_
27	activation	activation	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	Thus	thus	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	present	present	_	_	_	_	_	_	_
5	observations	observation	_	_	_	_	_	_	_
6	will	will	_	_	_	_	_	_	_
7	provide	provide	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	further	further	_	_	_	_	_	_	_
10	insight	insight	_	_	_	_	_	_	_
11	into	into	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	pathogenesis	pathogenesis	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	HIV-1	HIV-1	_	_	_	_	_	_	_
16	infections	infection	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

